Please use this identifier to cite or link to this item:
https://dspace.iiti.ac.in/handle/123456789/3985
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Roy, Anjali | en_US |
dc.contributor.author | Saqib, Uzma | en_US |
dc.contributor.author | Baig, Mirza Saqib | en_US |
dc.date.accessioned | 2022-03-17T01:00:00Z | - |
dc.date.accessioned | 2022-03-17T15:31:14Z | - |
dc.date.available | 2022-03-17T01:00:00Z | - |
dc.date.available | 2022-03-17T15:31:14Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | Roy, A., Banerjee, S., Saqib, U., & Baig, M. S. (2019). NOS1-derived nitric oxide facilitates macrophage uptake of low-density lipoprotein. Journal of Cellular Biochemistry, 120(7), 11593-11603. doi:10.1002/jcb.28439 | en_US |
dc.identifier.issn | 0730-2312 | - |
dc.identifier.other | EID(2-s2.0-85062347258) | - |
dc.identifier.uri | https://doi.org/10.1002/jcb.28439 | - |
dc.identifier.uri | https://dspace.iiti.ac.in/handle/123456789/3985 | - |
dc.description.abstract | Foam cell formation is a hallmark event during atherosclerosis. The current paradigm is that lipid uptake by a scavenger receptor in macrophages initiates necrosis core formation that characterizes atherosclerosis. We report that NOS1-derived nitric oxide (NO) facilitates low-density lipoprotein (LDL) uptake by macrophages independent of the inflammatory response. LDL uptake could be dramatically suppressed by NOS1 specific inhibitor 1-(2-trifluoromethylphenyl) imidazole (TRIM). Importantly, the notion that NOS1 can mediate uptake of lipoproteins suggests that the foam cell formation is regulated by NOS1-derived NO-mediated mechanism. This is a novel study involving NOS1 as a critical player of foam cell formation and reveals much about the key molecular proteins involved in atherosclerosis. Targeting NOS1 would be a useful strategy in reducing LDL uptake by macrophages and hence dampening the atherosclerosis progression. © 2019 Wiley Periodicals, Inc. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley-Liss Inc. | en_US |
dc.source | Journal of Cellular Biochemistry | en_US |
dc.subject | 1 (2 trifluoromethylphenyl)imidazole | en_US |
dc.subject | low density lipoprotein | en_US |
dc.subject | neuronal nitric oxide synthase | en_US |
dc.subject | nitric oxide | en_US |
dc.subject | scavenger receptor | en_US |
dc.subject | animal cell | en_US |
dc.subject | Article | en_US |
dc.subject | atherosclerosis | en_US |
dc.subject | controlled study | en_US |
dc.subject | enzyme inhibition | en_US |
dc.subject | enzyme regulation | en_US |
dc.subject | foam cell | en_US |
dc.subject | lipid transport | en_US |
dc.subject | macrophage | en_US |
dc.subject | nonhuman | en_US |
dc.subject | priority journal | en_US |
dc.subject | protein targeting | en_US |
dc.title | NOS1-derived nitric oxide facilitates macrophage uptake of low-density lipoprotein | en_US |
dc.type | Journal Article | en_US |
Appears in Collections: | Department of Biosciences and Biomedical Engineering |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
Altmetric Badge: